Loading...
XTAE
TGTR
Market cap13mUSD
Jul 09, Last price  
235.10ILS
1D
0.64%
1Q
-13.31%
Jan 2017
-67.92%
Name

Together Pharma Ltd

Chart & Performance

D1W1MN
XTAE:TGTR chart
P/E
21.33
P/S
0.37
EPS
0.11
Div Yield, %
—
Shrs. gr., 5y
22.34%
Rev. gr., 5y
58.01%
Revenues
110m
+14.13%
37,3371,189,3867,586,09612,114,113000011,130,00011,581,00031,228,00091,006,00096,053,000109,628,000
Net income
2m
P
-12,970,873-4,483,606-5,470,405-3,838,052-1,733,760-34,000-149,863,000-15,276,0007,152,000-13,776,000-33,524,000-4,316,000-1,172,0001,912,000
CFO
7m
+130.96%
-4,872,478-3,859,438-2,657,276-4,169,254-3,417,433-2,323,645-5,379,000-6,833,000-9,703,000-18,644,000-13,733,00014,831,0002,849,0006,580,000
Dividend
Mar 29, 20110.289062 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers cannabis oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.
URL
https://www.together-pharma.com/
IPO date
May 01, 1993
Employees
70
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT